CIK 0001861107 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Ceribell, Inc.
Sign in to watch- Ticker
- CBLL
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 471785452
- Phone
- (800) 436-0826
- Business address
- 360 N. PASTORIA AVENUE, SUNNYVALE, CA, 94085
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,415,987
- in 16 filings, $3.9M under 10b5-1 plans
Net −$4,415,987. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Chao Xingjuan −$2.5M President and CEO sold 12% of stake
- Blumberg Scott −$938K Chief Financial Officer sold 20% of stake
- Woo Raymond −$417K Chief Technology Officer sold 8% of stake
- Taylor Joseph Michael −$278K Director sold 21% of stake
- Foehr David −$269K Senior VP, Finance and PAO sold 25% of stake
Reading 16 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-22 | Blumberg Scott Chief Financial Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −4,752 | 24,543 | ||
| 2025-12-22 | Blumberg Scott Chief Financial Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −11,529 | 10,198 | ||
| 2025-12-22 | Blumberg Scott Chief Financial Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −19,719 | 44,093 | ||
| 2025-12-22 | Blumberg Scott Chief Financial Officer | Option exercise 10b5-1 | +4,752 | $3.65 | $17K | 123,594 |
| 2025-12-22 | Blumberg Scott Chief Financial Officer | Sale 10b5-1 | −4,752 | $21.00 | $100K | 118,842 |
| 2025-12-22 | Blumberg Scott Chief Financial Officer | Option exercise 10b5-1 | +11,529 | $3.65 | $42K | 130,371 |
| 2025-12-22 | Blumberg Scott Chief Financial Officer | Sale 10b5-1 | −11,529 | $21.00 | $242K | 118,842 |
| 2025-12-22 | Blumberg Scott Chief Financial Officer | Option exercise 10b5-1 | +19,719 | $4.70 | $93K | 138,561 |
| 2025-12-22 | Blumberg Scott Chief Financial Officer | Sale 10b5-1 | −19,719 | $21.00 | $414K | 118,842 |
| 2025-12-22 | Blumberg Scott Chief Financial Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −4,752 | 0 | ||
| 2025-12-22 | Blumberg Scott Chief Financial Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −11,529 | 0 | ||
| 2025-12-22 | Blumberg Scott Chief Financial Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −19,719 | 6,869 | ||
| 2025-12-15 | Parvizi Josef Director | Sale 10b5-1 | −25,000 | $21.49 | $537K | 772,652 |
| 2025-12-09 | BURKE WILLIAM W Director | Option exercise 10b5-1 | +9,728 | $2.26 | $22K | 27,119 |
| 2025-12-09 | BURKE WILLIAM W Director | Sale 10b5-1 | −9,728 | $22.02 | $214K | 17,391 |
| 2025-12-09 | BURKE WILLIAM W Director | Option exercise 10b5-1 | +23,000 | $4.70 | $108K | 40,391 |
| 2025-12-09 | BURKE WILLIAM W Director | Sale 10b5-1 | −23,000 | $22.02 | $506K | 17,391 |
| 2025-12-09 | BURKE WILLIAM W Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −9,728 | 0 | ||
| 2025-12-09 | BURKE WILLIAM W Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −23,000 | 25,151 | ||
| 2025-12-08 | Parvizi Josef Director | Sale 10b5-1 | −25,000 | $20.26 | $507K | 797,652 |
Page 12 of 17 · 330 trades